Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular Block in Patients Having Catheter-based Neurointerventional Procedures

NCT03322657 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03322657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03322657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular Block in Patients Having Catheter-based Neurointerventional Procedures
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Completed
Start date
November 14, 2017
Completion date
February 1, 2021
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, neuromuscular blockade